Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,680 public trials 1,031 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Recruiting

Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In

NCT06745908

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Chan Soon-Shiong Institute for Medicine El Segundo, California, United States
  • MemorialCare - Orange Coast Medical Center Fountain Valley, California, United States
  • OPN Healthcare INC Glendale, California, United States
View all 36 locations
View Trial Details
Recruiting

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

NCT06465069

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +72 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
View all 38 locations
View Trial Details
Recruiting

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

NCT07513376

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Smilow Cancer Center at Yale-New Haven ( Site 3253) New Haven, Connecticut, United States
  • Billings Clinic ( Site 3255) Billings, Montana, United States
  • NHO Revive Research Institute, LLC ( Site 3218) Lincoln, Nebraska, United States
  • Renown Regional Medical Center-Renown Health Medical Oncology ( Site 3207) Reno, Nevada, United States
View all 42 locations
View Trial Details
Recruiting

Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations

NCT07195695

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • ClinRé 001-022 (Premier Cancer Care and Infusion Center) Fresno, California, United States
  • OPN Healthcare, Inc. Glendale, California, United States
  • University of California Irvine Irvine, California, United States
  • Sutter Health Roseville, California, United States
View all 199 locations
View Trial Details
Recruiting

A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

NCT07680764

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Local Institution - 0170 Athens, Georgia, United States
  • Local Institution - 0034 Lexington, Kentucky, United States
  • Local Institution - 0171 Lexington, Kentucky, United States
  • Local Institution - 0123 Baltimore, Maryland, United States
View all 71 locations
View Trial Details
Recruiting

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

NCT06568939

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Ironwood Cancer and Research Center /ID# 276370 Chandler, Arizona, United States
  • University of Arkansas for Medical Sciences /ID# 272923 Little Rock, Arkansas, United States
  • Valkyrie Clinical Trials /ID# 271322 Los Angeles, California, United States
  • Yale New Haven Hospital /ID# 271584 New Haven, Connecticut, United States
View all 80 locations
View Trial Details
Recruiting

MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)

NCT07431827

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Instituto Alexander Fleming ( Site 0310) Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
  • Sanatorio Parque ( Site 0311) Rosario, Santa Fe Province, Argentina
  • Hospital Italiano de Buenos Aires-Clinical Oncology ( Site 0306) CABA, Argentina
  • Centro de Educación Médica e Investigaciones clínicas "Dr. Norberto Quirno" (CEMIC) ( Site 0309) CABA, Argentina
View all 72 locations
View Trial Details
Recruiting

An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) in Routine Clinical Practice Settings in Europe

NCT05363319

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Klinikum Klagenfurt Klagenfurt, Carinthia, Austria
  • Salzburger Landeskliniken (SALK) Salzburg, Austria
  • Le Groupe Hospitalier de la Region de Mulhouse et Sud Alsace, Emile Muller Hospital Mulhouse, Alsace, France
  • Hopitaux Universitaires de Strasbourg Strasbourg, Bas-Rhin, France
View all 49 locations
View Trial Details

Related conditions